Olga Voskresenskaya

Dr. Olga Voskresenskaya

I. M. Sechenov First Moscow State Medical University (Sechenov University)
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TATinkov Alexey
Tinkov Alexey
MPMonica M. B. Paoliello
Monica M. B. Paoliello
AMAksana N. Mazilina
Aksana N. Mazilina
ASAnatoly Skalny
Anatoly Skalny
AJAirton Cunha Martins Jr.
Airton Cunha Martins Jr.
Michael AschnerMichael Aschner
Michael Aschner
Understanding of the immediate mechanisms of Mn-induced neurotoxicity is rapidly evolving. We seek to provide a summary of recent findings in the field, with an emphasis to clarify existing gaps and future research directions. We provide, here, a brief review of pertinent discoveries related to Mn-induced neurotoxicity research from the last five years. Significant progress was achieved in understanding the role of Mn transporters, such as SLC39A14, SLC39A8, and SLC30A10, in the regulation of systemic and brain manganese handling. Genetic analysis identified multiple metabolic pathways that could be considered as Mn neurotoxicity targets, including oxidative stress, endoplasmic reticulum stress, apoptosis, neuroinflammation, cell signaling pathways, and interference with neurotransmitter metabolism, to name a few. Recent findings have also demonstrated the impact of Mn exposure on transcriptional regulation of these pathways. There is a significant role of autophagy as a protective mechanism against cytotoxic Mn neurotoxicity, yet also a role for Mn to induce autophagic flux itself and autophagic dysfunction under conditions of decreased Mn bioavailability. This ambivalent role may be at the crossroad of mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis. Yet very recent evidence suggests Mn can have toxic impacts below the no observed adverse effect of Mn-induced mitochondrial dysfunction. The impact of Mn exposure on supramolecular complexes SNARE and NLRP3 inflammasome greatly contributes to Mn-induced synaptic dysfunction and neuroinflammation, respectively. The aforementioned effects might be at least partially mediated by the impact of Mn on α-synuclein accumulation. In addition to Mn-induced synaptic dysfunction, impaired neurotransmission is shown to be mediated by the effects of Mn on neurotransmitter systems and their complex interplay. Although multiple novel mechanisms have been highlighted, additional studies are required to identify the critical targets of Mn-induced neurotoxicity.

15 November 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
LALuiza T. Akhmedzhanova
Luiza T. Akhmedzhanova
OVOlga Voskresenskaya
Olga Voskresenskaya
AIAleksei I. Isaikin
Aleksei I. Isaikin
EEElizaveta V. Ermilova
Elizaveta V. Ermilova
TNTatiana I. Nasonova
Tatiana I. Nasonova
ИИИсайкин Алексей Иванович
Исайкин Алексей Иванович
Acute disseminated encephalomyelitis (AEM) and acute transverse myelitis (OPM) are autoimmune demyelinating diseases of the central nervous system. Two clinical observations of AEM and OPM developed after suffering acute coronavirus infection (SARS-CoV-2) are presented. Differential diagnosis was carried out with multiple sclerosis, encephalitis of an infectious nature, compressive myelopathy, and opticomyelitis. Both observations show an almost complete recovery of lost functions. The pathogenetic mechanisms of the development of AEM and OPM in patients with coronavirus infection are discussed. The onset of central nervous system dysimmune lesion in the context of coronavirus infection makes it necessary to monitor the clinical situation with the involvement of a neurologist for timely diagnosis and determination of therapeutic tactics that can reduce the degree of disability of patients.

2 April 2018 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
OVOlga Voskresenskaya
Olga Voskresenskaya
NZN. B. Zakharova
N. B. Zakharova
YTYu. S. Tarasova
Yu. S. Tarasova
NTN. E. Tereshkina
N. E. Tereshkina
VPV. A. Perepelov
V. A. Perepelov
EPE. M. Perepelova
E. M. Perepelova
Cognitive impairment (CI) is a basis for the clinical presentation of chronic cerebral ischemia (CCI). However, the role of the mechanisms of inflammation and angiogenesis in the origin of CI is unclear, as is its relationship to the number and localization of foci during a neuroimaging examination. Objective: to investigate the relationship between the presence of CI, focal brain tissue changes, and the plasma and serum levels of vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein-1 (MCP-1) in patients with CCI. Patients and methods. Examinations were made in 59 patients with CCI and in 20 apparently healthy individuals. The investigators evaluated the cognitive status using the Mini-Mental State Examination (MMSE) and the clock drawing test), performed brain magnetic resonance imaging (MRI), duplex scanning of cerebral vessels, and determined laboratory indicators: the serum levels of MCP-1 and C-reactive protein, and the serum and plasma concentrations of VEGF. Results. The patients with CI were found to have higher values of inflammatory markers, lower serum and plasma concentrations of angiogenic factors, and a greater number of focal changes on MRI than those without CI (5.06±0.23 and 2.36±0.3 scores, respectively; p<0.05). Imbalance of angiogenic and antiangiogenic factors can cause disease progression and moderate vascular CI in patients with CCI.

4 March 2018 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
VTV. Yu. Tabakov
V. Yu. Tabakov
OZO. E. Zinov’eVa
O. E. Zinov’eVa
OVOlga Voskresenskaya
Olga Voskresenskaya
MSM. Yu. Skoblov
M. Yu. Skoblov

2 January 2024 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Open access
VBVictoria Bitsadze
Victoria Bitsadze
JKJamilya Khizroeva
Jamilya Khizroeva
ALArina Lazarchuk
Arina Lazarchuk
PSPolina Salnikova
Polina Salnikova
FYFidan Yagubova
Fidan Yagubova
AMAlexander Makatsariya
Alexander Makatsariya
Antiphospholipid syndrome in neonates and children is a rare, but in some cases life-threatening condition with arterial and/or venous thrombosis and/or non-thrombotic neurological, skin, ophthalmological and other manifestations. This review highlights the available information about the features of pediatric APS, including the rare catastrophic form, the differences between pediatric and adult APS, and the role of genetic thrombophilia in APS manifestation. The clinical manifestations and treatment options for APS in children may differ from those in adults, and prescribing therapy can be challenging due to the unique clinical and morphological characteristics of the pediatric patient. Pediatric APS may be a predictor of the development of certain autoimmune diseases and classic manifestations of APS in adulthood, therefore, a revision of the existing criteria for the diagnosis and treatment of APS in children is necessary.

21 August 2023 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
SDS. A. Dzhukkaeva
S. A. Dzhukkaeva
EEE. V. Ermilova
E. V. Ermilova
SNSh. R. Nabiev
Sh. R. Nabiev
OVOlga Voskresenskaya
Olga Voskresenskaya
Neuromyelitis optica spectrum disorders (NMOSD) are a group of autoimmune inflammatory demyelinating diseases of the central nervous system. In 2015, International Expert Panel established diagnostic criteria for NMOSD. The majority of patients with NMOSD have aquaporin-4 autoantibody (AQP4-IgG). This case describes a 43-year-old woman who presented with weakness in her limbs followed by intractable vomiting. One year and 3 months later, she experienced acute visual impairment, which recurred several times. MRI of the spinal cord revealed a T2-hyperintense signal lesion at the cervical level extending over 4 vertebral segments. MRI of the brain showed involvement of the brainstem. AQP4-IgG was detected in her blood serum. It took 30 months from the onset of symptoms to establish the correct diagnosis. During this time, several incorrect diagnoses were made, including ischemic stroke, functional movement disorder and vertebrobasilar insufficiency. As a result of delayed diagnosis and treatment, the patient developed severe irreversible visual impairment. This case underscores the importance of early diagnosis and early treatment of NMOSD.